Xiao Bai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiao Bai has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Guangmin Song
Department of Cardiovascular Surgery, Qilu Hospital of Shandong University, Jinan, China
3 shared publications - Zhuangzhuang Lu
Department of Cardiovascular Surgery, Qilu Hospital of Shandong University, Jinan, China
2 shared publications Chaqi Gai
Key Laboratory of High-Efficiency and Clean Mechanical Manufacture, Ministry of Education, School of Mechanical Engineering, Shandong University, Jinan, China
1 shared publicationChen Wang
Key Laboratory of High-Efficiency and Clean Mechanical Manufacture, Ministry of Education, School of Mechanical Engineering, Shandong University, Jinan, China
1 shared publicationDetian Jiang
1 shared publicationFu Shang
Key Laboratory of High-Efficiency and Clean Mechanical Manufacture, Ministry of Education, School of Mechanical Engineering, Shandong University, Jinan, China
1 shared publication
Latest Publications
- Open Access
- 17 July 2026
- Published by Springer Nature in Advanced Composites and Hybrid Materials
A permeable and stretchable liquid metal fiber enables ultrahigh-linearity and wide-range strain sensors
- 17 July 2026
- Published by Springer Nature in Advanced Composites and Hybrid Materials
Open AccessA permeable and stretchable liquid metal fiber enables ultrahigh-linearity and wide-range strain sensors
- 23 May 2026
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 481 (6) , 2639-2654
Integrative multi-omics and machine learning reveal glycolysis-related biomarkers driving vascular remodeling in pulmonary arterial hypertension
Metabolic reprogramming toward aerobic glycolysis, a phenomenon analogous to the Warburg effect, is increasingly recognized as a hallmark of pulmonary arterial hypertension (PAH). However, how glycolytic activation orchestrates pulmonary vascular remodeling and endothelial–mesenchymal transition (EndMT) remains poorly understood. To delineate the molecular determinants of glycolytic remodeling, we integrated bulk and single-cell transcriptomic datasets from hypoxia-induced (SuHx) PAH rat models. A multi-algorithm machine-learning pipeline combining LASSO, BORUTA, and SVM-RFE was employed to identify glycolysis-related hub genes. Diagnostic performance was validated in independent rat and human datasets, followed by single-cell communication and pseudotime trajectory analyses to infer cellular dynamics. Experimental verification was performed using SuHx/MCT rat models and hypoxia-treated HUVECs. Five glycolysis-related biomarkers—Cxcr4, Pfkfb3, Rgcc, MGC105649, and Mt2A—were identified, exhibiting consistent differential expression across datasets. PFKFB3 and MT2A emerged as core regulators that link glycolytic activation with endothelial–fibroblast crosstalk and EndMT. Single-cell and pseudotime analyses revealed that endothelial cells progressively transition toward mesenchymal-like phenotypes under hypoxia, accompanied by enhanced glycolytic signaling. Functional validation confirmed increased expression of PFKFB3 and MT2A in vivo and demonstrated that hypoxia and lactate synergistically promote endothelial proliferation in vitro. This integrative framework combining multi-omics and machine learning uncovers a glycolysis-driven EndMT axis that underlies pulmonary vascular remodeling. The identified biomarkers provide mechanistic insight into metabolic–structural coupling in PAH and highlight PFKFB3 and MT2A as promising molecular targets for future glycolysis-based therapeutic interventions.
- 23 May 2026
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 481 (6) , 2639-2654
Integrative multi-omics and machine learning reveal glycolysis-related biomarkers driving vascular remodeling in pulmonary arterial hypertension
Metabolic reprogramming toward aerobic glycolysis, a phenomenon analogous to the Warburg effect, is increasingly recognized as a hallmark of pulmonary arterial hypertension (PAH). However, how glycolytic activation orchestrates pulmonary vascular remodeling and endothelial–mesenchymal transition (EndMT) remains poorly understood. To delineate the molecular determinants of glycolytic remodeling, we integrated bulk and single-cell transcriptomic datasets from hypoxia-induced (SuHx) PAH rat models. A multi-algorithm machine-learning pipeline combining LASSO, BORUTA, and SVM-RFE was employed to identify glycolysis-related hub genes. Diagnostic performance was validated in independent rat and human datasets, followed by single-cell communication and pseudotime trajectory analyses to infer cellular dynamics. Experimental verification was performed using SuHx/MCT rat models and hypoxia-treated HUVECs. Five glycolysis-related biomarkers—Cxcr4, Pfkfb3, Rgcc, MGC105649, and Mt2A—were identified, exhibiting consistent differential expression across datasets. PFKFB3 and MT2A emerged as core regulators that link glycolytic activation with endothelial–fibroblast crosstalk and EndMT. Single-cell and pseudotime analyses revealed that endothelial cells progressively transition toward mesenchymal-like phenotypes under hypoxia, accompanied by enhanced glycolytic signaling. Functional validation confirmed increased expression of PFKFB3 and MT2A in vivo and demonstrated that hypoxia and lactate synergistically promote endothelial proliferation in vitro. This integrative framework combining multi-omics and machine learning uncovers a glycolysis-driven EndMT axis that underlies pulmonary vascular remodeling. The identified biomarkers provide mechanistic insight into metabolic–structural coupling in PAH and highlight PFKFB3 and MT2A as promising molecular targets for future glycolysis-based therapeutic interventions.
- 12 September 2022
- Published by IMR Press in The Heart Surgery Forum
- Vol. 25 (5) , E756-E767
Analysis of Influencing Factors of Surgical Options for Coronary Atherosclerotic Heart Disease Complicated with Moderate Ischemic Mitral Regurgitation
Background: There are several controversies regarding the surgical approach for patients with coronary atherosclerotic heart disease (CAHD) complicated with moderate ischemic mitral regurgitation (IMR). Methods: A retrospective study was performed among 115 patients divided into two groups. Clinical and echocardiographic parameters, including perioperative indexes and follow ups, degree of stenosis in the coronary arteries, and cardiac function index, were analyzed. Patients who died in the hospital due to complications during the perioperative period were defined as the deterioration group (deterioration of coronary artery bypass grafting, CABG vs. deterioration of coronary artery bypass grafting combined with mitral valve surgery, CABG+MVS: N = 7, 58.3% vs. N = 5, 41.7%), whereas the remaining patients were defined as the rehabilitation group (rehabilitation of CABG vs. rehabilitation of CABG+MVS: N = 52, 50.5% vs. N = 51, 49.5%). Data were compared between the rehabilitation of the CABG and CABG+MVS groups to explore the predictors for surgical method selection. Results: Postoperative patients who died during hospitalization were excluded (N = 12). At 1-year follow up, there were 52 patients in the CABG rehabilitation group and 51 in the CABG+MVS rehabilitation group. During the follow-up period, 10 patients died (rehabilitation of CABG vs. rehabilitation of CABG+MVS: N = 7, 13.7% vs. N = 3, 5.8%). Nevertheless, the difference was not statistically significant. The logistic regression analysis identified four independent factors when choosing the surgical modality: prior-myocardial infarction (prior-MI), preoperative atrial fibrillation (pre-AF), and the stenotic degree of the left circumflex (LCX) and left main (LM) arteries. Conclusions: Prior-MI, pre-AF, and the degree of stenosis in LCX and LM could influence the choice of surgical method. This study provided new insights into the treatment of CAHD with moderate IMR.
- 12 September 2022
- Published by IMR Press in The Heart Surgery Forum
- Vol. 25 (5) , E756-E767
Analysis of Influencing Factors of Surgical Options for Coronary Atherosclerotic Heart Disease Complicated with Moderate Ischemic Mitral Regurgitation
Background: There are several controversies regarding the surgical approach for patients with coronary atherosclerotic heart disease (CAHD) complicated with moderate ischemic mitral regurgitation (IMR). Methods: A retrospective study was performed among 115 patients divided into two groups. Clinical and echocardiographic parameters, including perioperative indexes and follow ups, degree of stenosis in the coronary arteries, and cardiac function index, were analyzed. Patients who died in the hospital due to complications during the perioperative period were defined as the deterioration group (deterioration of coronary artery bypass grafting, CABG vs. deterioration of coronary artery bypass grafting combined with mitral valve surgery, CABG+MVS: N = 7, 58.3% vs. N = 5, 41.7%), whereas the remaining patients were defined as the rehabilitation group (rehabilitation of CABG vs. rehabilitation of CABG+MVS: N = 52, 50.5% vs. N = 51, 49.5%). Data were compared between the rehabilitation of the CABG and CABG+MVS groups to explore the predictors for surgical method selection. Results: Postoperative patients who died during hospitalization were excluded (N = 12). At 1-year follow up, there were 52 patients in the CABG rehabilitation group and 51 in the CABG+MVS rehabilitation group. During the follow-up period, 10 patients died (rehabilitation of CABG vs. rehabilitation of CABG+MVS: N = 7, 13.7% vs. N = 3, 5.8%). Nevertheless, the difference was not statistically significant. The logistic regression analysis identified four independent factors when choosing the surgical modality: prior-myocardial infarction (prior-MI), preoperative atrial fibrillation (pre-AF), and the stenotic degree of the left circumflex (LCX) and left main (LM) arteries. Conclusions: Prior-MI, pre-AF, and the degree of stenosis in LCX and LM could influence the choice of surgical method. This study provided new insights into the treatment of CAHD with moderate IMR.
- 12 September 2022
- Published by IMR Press in The Heart Surgery Forum
- Vol. 25 (5) , E784-E792
Predictive Efficacy of the Index of Microcirculatory Resistance for Acute Allograft Rejection and Cardiac Events After Heart Transplantation: A Systematic Review and Meta-Analysis
Background: In patients treated by heart transplantation, the index of microcirculatory resistance (IMR) has been found to have predictive potential for subsequent acute allograft rejection (AAR) and long-time cardiac events. When consulting related literature, the studies mostly were single-center with small sample sizes. The question of whether IMR can be utilized as a predictive biomarker is becoming increasingly contentious. To confirm the predictive efficacy of IMR, researchers did a systematic review and meta-analysis. Method: From inception to April 2022, PubMed, EMBASE, Cochrane Library, Web of Science, Ovid, ProQuest, and Scopus systematically were searched. The results were presented as pooled ratio rate (RR) with 95% confidence intervals (CI). Assessment of the quality, heterogeneity analyses, and publication bias analysis also were performed. Results: A total of 616 patients were studied in five trials. There were significant differences in subsequent AAR (RR = 4.08; 95% CI: 2.69~6.17; P = 0.000) or long-time cardiac events (RR=2.14; 95% CI: 1.44~3.19; P = 0.000) between IMR-high and IMR-low patients in the forest plots. Patients treated with heart transplantation in the high IMR group had better predictive efficacy than the low IMR group. Conclusions: High IMR could predict the events of subsequent AAR and cardiac events after heart transplantation. This will help reduce the occurrence of adverse events and personalize treatment for patients.
- 12 September 2022
- Published by IMR Press in The Heart Surgery Forum
- Vol. 25 (5) , E784-E792
Predictive Efficacy of the Index of Microcirculatory Resistance for Acute Allograft Rejection and Cardiac Events After Heart Transplantation: A Systematic Review and Meta-Analysis
Background: In patients treated by heart transplantation, the index of microcirculatory resistance (IMR) has been found to have predictive potential for subsequent acute allograft rejection (AAR) and long-time cardiac events. When consulting related literature, the studies mostly were single-center with small sample sizes. The question of whether IMR can be utilized as a predictive biomarker is becoming increasingly contentious. To confirm the predictive efficacy of IMR, researchers did a systematic review and meta-analysis. Method: From inception to April 2022, PubMed, EMBASE, Cochrane Library, Web of Science, Ovid, ProQuest, and Scopus systematically were searched. The results were presented as pooled ratio rate (RR) with 95% confidence intervals (CI). Assessment of the quality, heterogeneity analyses, and publication bias analysis also were performed. Results: A total of 616 patients were studied in five trials. There were significant differences in subsequent AAR (RR = 4.08; 95% CI: 2.69~6.17; P = 0.000) or long-time cardiac events (RR=2.14; 95% CI: 1.44~3.19; P = 0.000) between IMR-high and IMR-low patients in the forest plots. Patients treated with heart transplantation in the high IMR group had better predictive efficacy than the low IMR group. Conclusions: High IMR could predict the events of subsequent AAR and cardiac events after heart transplantation. This will help reduce the occurrence of adverse events and personalize treatment for patients.
- Open Access
- 1 August 2021
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 13 (8) , 5077-5092
Mesenchymal stem cells transfected with anti-miRNA-204-3p inhibit acute rejection after heart transplantation by targeting C-X-C motif chemokine receptor 4 (CXCR4) in vitro
Background: Mesenchymal stem cells (MSCs) are a promising treatment for acute rejection (AR) after heart transplantation (HTx) owing to their immunomodulatory functions by promoting the transformation of macrophages from the M0 to M2 phenotype. However, it is undetermined whether surface expression of C-X-C motif chemokine receptor 4 (CXCR4) by MSCs influences macrophage polarization. In this study, we investigated the effects of MSCs on macrophages caused by CXCR4, and detected the underlying mechanism, which may contribute to improving HTx outcomes. Methods: The MSCs were extracted from rat bone marrow and identified using flow cytometry. We subsequently observed the effects of CXCR4 and anti-miRNA-204-3p on cell proliferation and migration, and the effects on macrophage polarization. Dual luciferase reporter assay was used to explore whether miRNA-204-3p was an upstream microRNA (miRNA) of CXCR4. A series of rescue experiments were performed to further confirm the inhibitory effect of miRNA-204-3p on CXCR4. Results: The results showed that CXCR4 could promote the proliferation and migration of MSCs. Furthermore, it facilitated MSC-mediated macrophage transformation from the M0 to M2 phenotype. In addition, miRNA-204-3p inhibited the function of CXCR4 of MSCs. Conclusions: Regulated by miRNA-204-3p, CXCR4 could inhibit the progression of AR after HTx. This study provides a new insight of the treatment of AR after HTx.
- 1 August 2021
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 13 (8) , 5077-5092
Open AccessMesenchymal stem cells transfected with anti-miRNA-204-3p inhibit acute rejection after heart transplantation by targeting C-X-C motif chemokine receptor 4 (CXCR4) in vitro
Background: Mesenchymal stem cells (MSCs) are a promising treatment for acute rejection (AR) after heart transplantation (HTx) owing to their immunomodulatory functions by promoting the transformation of macrophages from the M0 to M2 phenotype. However, it is undetermined whether surface expression of C-X-C motif chemokine receptor 4 (CXCR4) by MSCs influences macrophage polarization. In this study, we investigated the effects of MSCs on macrophages caused by CXCR4, and detected the underlying mechanism, which may contribute to improving HTx outcomes. Methods: The MSCs were extracted from rat bone marrow and identified using flow cytometry. We subsequently observed the effects of CXCR4 and anti-miRNA-204-3p on cell proliferation and migration, and the effects on macrophage polarization. Dual luciferase reporter assay was used to explore whether miRNA-204-3p was an upstream microRNA (miRNA) of CXCR4. A series of rescue experiments were performed to further confirm the inhibitory effect of miRNA-204-3p on CXCR4. Results: The results showed that CXCR4 could promote the proliferation and migration of MSCs. Furthermore, it facilitated MSC-mediated macrophage transformation from the M0 to M2 phenotype. In addition, miRNA-204-3p inhibited the function of CXCR4 of MSCs. Conclusions: Regulated by miRNA-204-3p, CXCR4 could inhibit the progression of AR after HTx. This study provides a new insight of the treatment of AR after HTx.